SLC16A1 and breast cancer: The blockade of the lactate transporter MCT1 has shown to reduce the proliferation of breast cancer cells co‐expressing MCT1 and MCT4 (Hong et al., 2016), and decrease HIF‐1α‐induced angiogenesis in cervix squamous carcinoma (Sonveaux et al., 2008, 2012).